References
- Toker C. Clear cells of the nipple epidermis. Cancer 1970. 25: 601–10.
- Nagle RB, Lucas DO, McDaniel KM, Clark VA, Schmalzel GM. Paget's cells. New evidence linking mammary and extramammary Paget cells to a common cell phenotype. Am J Clin Pathol 1985. 83: 431–8.
- van der Putte SC, Toonstra J, Hennipman A. Mammary Paget's disease confined to the areola and associated with multifocal Toker cell hyperplasia. Am J Dermatopathol 1995. 17: 487–93.
- Kohler S, Rouse RV, Smoller BR. The differential diagnosis of pagetoid cells in the epidermis. Mod Pathol 1998. 11: 79–92.
- Decaussin M, Laville M, Mathevet P, Frappart L. Paget's disease versus Toker cell hyperplasia in a supernumerary nipple. Virchows Arch 1998. 432: 289–91.
- Lundquist K, Kohler S, Rouse RV. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells. Am J Surg Pathol 1999. 23: 212–9.
- Willman JH, Golitz LE, Fitzpatrick JE. Clear cells of Toker in accessory nipples. J Cutan Pathol 2003. 30: 256–60.
- Lammie GA, Barnes DM, Millis RR, Gullick WJ. An immunohistochemical study of the presence of c-erbB-2 protein in Paget's disease of the nipple. Histopathology 1989. 15: 505–14.
- Keatings L, Sinclair J, Wright C, et al c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology 1990. 17: 243–7.
- Wolber RA, Dupuis BA, Wick MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease. Am J Clin Pathol 1991. 96: 243–7.
- Manavi M, Hudelist G, Schatten C, Battistutti WB, Pischinger KI, Czerwenka KF. Characteristics of clear cells and Toker cells in the epidermis of underlying nipple duct adenoma. Anticancer Res 2002. 22: 3691–700.
- Di Tommaso L, Franchi G, Destro A, et al Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases. Hum Pathol 2008. 39: 1295–300.
- Wolff AC, Hammond ME, Schwartz JN, et al American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007. 25: 118–45.
- Spyratos F, Ferrero-Pous M, Trassard M, et al Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Cancer 2002. 94: 2151–9.
- Guarner J, Cohen C, DeRose PB. Histogenesis of extramammary and mammary Paget cells. An immunohistochemical study. Am J Dermatopathol 1989. 11: 313–8.
- Haerslev T, Krag Jacobsen G. Expression of cytokeratin and erbB-2 oncoprotein in Paget's disease of the nipple. An immunohistochemical study. APMIS 1992. 100: 1041–7.
- Yao DX, Hoda SA, Chiu A, Ying L, Rosen PP. Intraepidermal cytokeratin 7 immunoreactive cells in the non-neoplastic nipple may represent interepithelial extension of lactiferous duct cells. Histopathology 2002. 40: 230–6.
- Wauters CC, Smedts F, Gerrits LG, Bosman FT, Ramaekers FC. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995. 26: 852–5.
- Morandi L, Pession A, Marucci GL, et al Intraepidermal cells of Paget's carcinoma of the breast can be genetically different from those of the underlying carcinoma. Hum Pathol 2003. 34: 1321–30.